Number of pages: 41
Posted: 06 Apr 2021
Matthew J. Gorman,
Nita Patel,
Mimi Guebre-Xabier,
Alex L. Zhu,
Caroline Atyeo,
Krista M. Pullen,
Carolin Loos,
Yenny Goez-Gazi,
Ricardo Carrion,
Jing-Hui Tian,
Dansu Yaun,
Kathryn Bowman,
Bin Zhou,
Sonia Maciejewski,
Marisa E. McGrath, James Logue,
Matthew B. Frieman,
David C. Montefiori,
Colin Mann,
Sharon Schendel,
Fatima Amanat,
Florian Krammer,
Erica Ollmann Saphire,
Douglas Lauffenburger,
Ann M. Greene,
Alyse D. Portnoff,
Michael J. Massare,
Larry Ellingsworth,
Gregory M. Glenn,
Gale Smith and
Galit Alter
Ragon Institute of MGH, MIT and Harvard, Novavax, Inc., Novavax, Inc., Ragon Institute of MGH, MIT and Harvard, Ragon Institute of MGH, MIT and Harvard, Massachusetts Institute of Technology - Department of Biological Engineering, Ragon Institute of MGH, MIT and Harvard, Texas Biomedical Research Institute, Texas Biomedical Research Institute, Novavax, Inc., Ragon Institute of MGH, MIT and Harvard, Ragon Institute of MGH, MIT and Harvard, Novavax, Inc., Novavax, Inc., University of Maryland - School of Medicine, University of Maryland - School of Medicine, University of Maryland - School of Medicine, Duke University - Duke Human Vaccine Institute, La Jolla Institute for Allergy and Immunology (LIAI), La Jolla Institute for Allergy and Immunology (LIAI), Icahn School of Medicine at Mount Sinai - Department of Microbiology, Icahn School of Medicine at Mount Sinai - Department of Microbiology, La Jolla Institute for Allergy and Immunology (LIAI) - Center for Infectious Disease and Vaccine Research, Massachusetts Institute of Technology (MIT) - Department of Biological Engineering, Novavax, Inc., Novavax, Inc., Novavax, Inc., Novavax, Inc., Novavax, Inc., Novavax, Inc. and MassachusettsGeneral Hospital - Ragon Institute of MGH, MIT and Harvard
